Report
GlobalData Healthcare Department
EUR 114.00 For Business Accounts Only

Klyss Biotech Inc - Company Review

Klyss Biotech Inc - Company Review

Summary

Klyss Biotech Inc (Klyss Biotech) focuses on the development of monoclonal antibody cancer therapies. The company’s lead product candidate ch128.1, is an antibody therapeutic that targets transferrin receptor (TfR) which is also known as CD71. It offers antibodies for the treatment of hematological malignancies, including cancers, such as multiple myeloma and non-Hodgkin lymphomas. Klyss Biotech is headquartered in Santa Monica, California, the US.

This comprehensive company report of Klyss Biotech Inc provides you with company's businesses and operations information.

The profile contains critical company information including,

- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Provider
GlobalData Plc
GlobalData Plc

​GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.

Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.

Analysts
GlobalData Healthcare Department

Other Reports from GlobalData Plc

ResearchPool Subscriptions

Get the most out of your insights

Get in touch